HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hagström-Toft, E. Articles by Arner, P. Search for Related Content PubMed PubMed Citation Articles by Hagström-Toft, E. Articles by Arner, P. Social Bookmarking                What's this?

Marked Heterogeneity of Human Skeletal Muscle Lipolysis at Rest

¹ Department of Medicine, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
² Department of Pathology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
³ Department of Rheumatology, Karolinska Hospital, Stockholm, Sweden

	ABSTRACT

TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES

 
In this study, variations in lipolysis among different muscle groups were examined by measuring local net glycerol release in vivo in healthy, normal-weight subjects (n = 11) during rested, postabsorptive conditions. Microdialysis of the gastrocnemius, deltoid, and vastus lateralis muscle regions revealed that extracellular glycerol concentrations of these three muscle regions were 84.7 ± 6.7, 59.7 + 7.3, and 56.4 ± 7.5 µmol/l, respectively, and the arterial plasma glycerol concentration was 44.8 ± 2.3 µmol/l (P = 0.0003–0.006, gastrocnemius vs. others). Local tissue blood flow, as measured by Xe clearance, did not differ among the regions. Net glycerol release was significantly higher in gastrocnemius muscle than in the two other regions. There were no regional differences in glycerol uptake when studied during glycerol infusion. Gastrocnemius muscle showed a dominance of type 1 fibers (70%), whereas the vastus lateralis muscle had equal distribution of fiber types (P = 0.02). No differences in intramuscular triaclyceride content, perimuscular fat, or the adipocyte-specific protein perilipin were observed among the muscle regions. Triglyceride turnover in the gastrocnemius muscle was 3.3 + 1.4% over 24 h, which is about 10 times more rapid than the turnover rate in subcutaneous adipose tissue (P < 0.01). Thus there were marked differences in lipolytic activity among skeletal muscle groups at rest, possibly reflecting variations in fiber type.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES

Another important aspect of lipolysis is whether its activity is subject to regional variations. Such variations do exist for adipose tissue (17). Lipolysis is more easily stimulated and less readily inhibited in the visceral, as compared with the subcutaneous, region. It is not known whether lipolysis also differs between muscle groups. Human skeletal muscle is a heterogeneous tissue with respect to both function and fiber composition (i.e., containing slow-twitch type 1 and fast-twitch type 2 fibers). It has been shown in rats that the rates of TG synthesis and hydrolysis differ markedly among muscle groups (18,19).

The aim of the present study was to determine whether lipolytic activity in humans differs among various muscle groups at rest, and if any differences could be related to TG content and/or fiber composition of the muscle. The deltoid, vastus lateralis, and gastrocnemius muscle groups were chosen to reflect a range of function. Local lipolytic activity was estimated by combining arterial and tissue measurements of glycerol with estimations of muscle blood flow using the microdialysis and Xe-washout techniques, respectively (8). We found marked differences in net glycerol release among the muscle groups, which were likely related to fiber composition.

	RESEARCH DESIGN AND METHODS

TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES

 
Subjects.
The study group was comprised of 11 healthy, nonobese, Caucasian volunteers (6 men and 5 women). None of the subjects was on regular medication. All undertook light or regular physical activities; none was involved in athletic performance. Their mean age (±SE) was 32 ± 3 years (22–51), and their BMI averaged 22.1 ± 0.9 kg/m². The Ethics Committee of the Karolinska Institutet approved the study. We obtained permission to take biopsies from vastus lateralis and gastrocnemius muscle only. The subjects were given a detailed description of the study and their consent was obtained. To avoid acute effects, the subjects were instructed not to perform physical exercise 24 h before the experiments were carried out.

Protocols
Microdialysis.
In all subjects, glycerol concentrations in the intercellular space of the three different skeletal muscle tissue regions were determined using microdialysis, as described in detail elsewhere (8,20). Briefly, a double lumen catheter, with a semipermeable membrane glued to its end, was inserted percutaneously in the tissue and perfused with a sterile solution. An exchange of molecules will take place over the membrane, and the composition of the outflow solution will reflect that of the extracellular space. Only small substances will pass across the membrane, so the samples are therefore protected from enzymatic degradation. Optimization of the catheter length and perfusion speed gives an almost complete recovery, whereby the outgoing concentration of glycerol equals the true interstitial tissue level.

The subjects reported to the laboratory at 8:00 A.M. after an overnight fast. Teflon catheters (Venflon) were inserted in a retrograde manner in the dorsal hand vein for blood sampling. The hand was placed in an air-heated box (63°C) to ensure arterialization of the venous blood (21). Microdialysis catheters (0.3 x 30 mm, 20-kDa molecular weight cutoff; CMA Microdialysis AB, Solna, Sweden) were inserted in the medial part of the gastrocnemius muscle, mid-part of the vastus lateralis muscle, and posterior part of the deltoid muscle, respectively, after topical anesthesia (EMLA, Astra, Sweden). The thickness of the subcutaneous tissue at the site of insertion was determined by ultrasound (5–15 mm) to ensure intramuscular location of the microdialysis device. In addition, the penetration of the muscular fascia was in most cases easily recognized, and the intramuscular location was confirmed by the development of muscular twitches during insertion.

Immediately after insertion, the microdialysis catheters were perfused with Ringer’s solution (147 mmol/l sodium, 4 mmol/l potassium, 2.3 mmol/l calcium, 156 mmol/l chloride; Apoteksbolaget, Umeå, Sweden) using a flow rate of 0.3 µl/min. This rate has previously been shown to give near-complete recovery of glycerol in skeletal muscle tissue (22); hence, the dialysate glycerol concentration acquired is very close to the glycerol concentration in the tissue extracellular space. After an equilibration period of 120 min, the dialysates were sampled in 15-min time fractions during a 90-min period. Plasma samples were drawn in the middle of each dialysate fraction. It has been previously demonstrated that the muscle tissue level of glycerol is at steady state 2 h after catheter insertion (22).

To study local uptake of glycerol, six of the subjects (three women, three men) were investigated with a similar microdialysis protocol on a second occasion. After a baseline sampling period, the circulating glycerol concentration was raised by means of a 3-h infusion of triacylglycerol emulsion (Intralipid 200 mg/ml; Pharmacia) at 1.85 ml · kg^-1 · h^-1. Blood sampling for the analysis of glycerol and TGs was carried out throughout the experiment. Microdialysis catheters were inserted as described above in the three muscle regions and, in addition, in abdominal adipose tissue in the periumbilical region for the analysis of dialysate glycerol.

Blood flow.
For practical reasons, in the first study tissue blood flow had to be registered on a separate occasion using the ¹³³Xe-washout method (23), as previously described in detail (8). The subjects came to the laboratory in the morning after an overnight fast. ¹³³Xe (0.3 MBq in 0.1 ml saline; Mallinckrodt, Petten, the Netherlands) was injected in the respective skeletal muscle tissue region. Residual activities were recorded with a scintillation detector (Mediscint; Oakfield Instruments, Oxford, U.K.). Recordings were started 5 min after the injection and continued for 30 min. Because the decay curve becomes multiexponential over time (24), only the first 10 min of the skeletal muscle decay curve were used for calculations. We recently demonstrated that muscle tissue blood flow measured in this way is stable over time. The coefficient of variation for determinations on two separate occasions is 20.6% (25). Therefore, blood flow was considered to be the same as during microdialysis.

For the glycerol-infusion study, skeletal muscle blood flow was determined with the same method. ¹³³Xe was injected as described above in the three skeletal muscle regions, opposite to the microdialysis site. Recordings were performed during the last 30 min of the baseline period. Because of changes in the decay curve, the injection had to be iterated and recordings again performed during the last 30 min of the infusion period. For determination of adipose tissue blood flow, Xe (1 MBq in 0.1 ml saline) was injected into the subcutaneous abdominal tissue contralaterally to the microdialysis catheter 30 min before the start of the baseline period. Recordings were performed throughout the experiment, and the blood flow was determined for the last 30-min period of baseline and infusion, respectively.

Muscle biopsies.
Percutaneous muscle biopsies were carried out in two of the three investigated regions: the vastus lateralis and gastrocnemius muscle. All subjects were asked to undergo biopsies, but only half of the group (three men and three women) were willing to do so. Because of practical reasons, it was not possible to perform the biopsies concomitantly with either the microdialysis or blood flow experiments. The biopsies were always performed after the microdialysis experiment. With the patient in the supine position, under sterile conditions, the skin and fascia were penetrated with a 1-cm cut after local anesthesia. Using a Weil-Blakesly nasal cutting forceps 100 mg muscle tissue were cut out from the middle region of the vastus lateralis muscle and the medial part of the gastrocnemius muscle. The specimens were trimmed from adipose and connective tissue and then frozen at -70°C in liquid nitrogen for biochemical analyses. For histological examination, the biopsies were snap frozen in isopentane and chilled with dry ice. Then 8- µm-thick cryostat sections were stained with hematoxylin-eosin (H-E), oil red O, sudan black, and ATPase with preincubation at pH 4.3 and 9.6.

Protein isolation and Western blot.
Total protein lysates were obtained from frozen subcutaneous adipose tissue or muscle tissue and then crushed and lysed in protein lysis buffer (1% Triton-X100, Tris-HCL [pH 7.6], and 150 mmol/l NaCl) supplemented with protease inhibitors (1 mmol/l phenylmethylsulfonyl fluoride and Complete [Roche, Basel, Switzerland]), as previously described (26). The protein content in each sample was determined using a kit of reagents from Pierce (Rockford, IL). Next, 50 (adipose tissue) or 300 µg (muscle tissue) of total protein were loaded on 12% polyacrylamide gels and separated by standard SDS-PAGE. To control for differences in gel migration, exposure time, and antibody incubation, among others, samples were run on the same gels and transferred to the same polyvinylidine fluoride membranes (Amersham Pharmacia Biotech, Little Chalfont, U.K.). After a standard blocking procedure, blots were incubated in the presence of either polyclonal antibodies directed against human hormone sensitive lipase (kindly provided by Dr. Cecilia Holm, Lund University, Sweden) or human perilipin (Progen Biotechnik GmBh, Heidelberg, Germany). Proteins were detected by chemiluminescence using Super Signal (Pierce Chemical, Rochford, IL). Films were scanned and quantified by NIH Image software (National Institutes of Health, Bethesda, MD).

Analytical procedures.
Microdialysate glycerol was determined with an enzymatic fluorometric method, using a tissue sample analyzer (CMA/60; CMA Microdialysis, Stockholm, Sweden) (16). Plasma glycerol was determined by bioluminescence (27). Muscle triacylglycerol content was determined after extraction of total lipids, as previously described (28). Extracts were dried and then saponified to FFAs and glycerol with KOH, as previously described (28). Glycerol, which is stoichiometrically equivalent to the TG concentration, was then determined by bioluminescence (27). Myofibrillar ATPase staining was used to identify muscle fiber types (29).

Calculations.
Tissue blood flow (TBF) was calculated according to the following formula:

where K denotes the rate constant of the decay of the residual activity and the tissue-to-blood partition coefficient (10 ml/g for fat and 0.7 ml/g for muscle) (23,30).

Glycerol release from the tissues was calculated according to Fick’s principle, as follows:

and venous glycerol was calculated from interstitial glycerol (I) as follows:

where V denotes venous glycerol, A denotes arterial glycerol, Q denotes calculated plasma blood flow, and PS denotes the permeability surface product area (adapted to be 5 ml · 100 g^-1 · min^-1) (31).

Although glycerol is perfectly water soluble, it uses transport systems in human red cells (32). These transporters probably belong to the "aquaporin" gene family (33). An aquaporin with a high affinity for glycerol (aquaporin-3) is present in human erythrocytes (34). Therefore, a correction for hematocrit was used in the present and previous microdialysis studies by us and others when Fick’s principle is applied to the calculation of net release of glycerol from adipose tissue and muscle. However, for comparison, the net glycerol release was also calculated without the correction for hematocrit.

Turnover rates of the tissue TG pool were calculated in the six subjects undergoing biopsies using the following parameters: wet weight of tissue (A), moles of TG in the tissue (B; for muscle, is the amount of glycerol after lipid extraction and hydrolysis), and the rate of glycerol mobilization from tissue per unit of tissue weight (C). The turnover rate, expressed as percent per 24 h, was calculated as B divided by A divided by C.

Statistics.
Data are means ± SE. Comparisons among the muscle groups were performed using Student’s paired or unpaired t test or Wilcoxon’s signed-rank test, where applicable. ANOVA was used for comparisons of parameters over time. Statistical calculations were made using a statistical software package (Statview II; Abacus Concepts, Berkeley, CA).

	RESULTS

TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES

 
Microdialysis and blood flow.
The glycerol concentrations in plasma and the three skeletal muscle regions are shown in Fig. 1. Glycerol was constant over time in all compartments (NS by one-way ANOVA repeated measures) and thus in steady state. The mean glycerol concentrations (Fig. 1B) in gastrocnemius were twofold higher than circulating glycerol and significantly higher than in the other muscle groups (plasma 44.8 ± 2.3, deltoid muscle 59.7 ± 7.3, vastus lateralis muscle 56.4 ± 7.5, and gastrocnemius muscle 84.7 ± 6.7 µmol/l; P = 0.0003–0.006). The interstitial-arterial (IA) glycerol difference, which represents the fractional release/extraction of the metabolite by the muscle, was calculated, and were 13.8 ± 7.3, 5.4 ± 8.8, and 40.0 ± 7.2 µmol/l for the deltoid, vastus lateralis, and gastrocnemius muscle regions, respectively. Values for the deltoid and vastus lateralis did not differ from each other or from zero. In contrast, the gastrocnemius IA glycerol difference differed from zero (P = 0.0005) and was significantly higher than values for the other two muscle regions (P = 0.003–0.01). In addition, we calculated the IA difference using calculated whole-blood values for glycerol (35), which were 19.5 + 8.0, 16.1 + 7.7, and 44.0 + 8.0 µmol/l for the deltoid, vastus lateralis, and gastrocnemius muscle, respectively. Again, the gastrocnemius IA glycerol difference differed from zero (P = 0.001) and was significantly higher than values for the other two muscle regions (P = 0.002–0.02). The skeletal muscle blood flow was similar in the three muscle regions (Table 1).

View larger version (30K): [in this window] [in a new window]   FIG. 1. Glycerol concentrations in the extracellular space of three different skeletal muscle tissue groups (deltoid, vastus lateralis, and gastrocnemius) and in plasma. Shown are the absolute glycerol concentration in each compartment (A) and the mean glycerol concentrations (B). Microdialysis catheters were inserted percutaneously and perfused with Ringer’s solution at 0.3 µl/min. Repeated samples of dialysates were collected over 90 min and glycerol levels were analyzed. Plasma was drawn in the middle of each dialysate time fraction (15 min).

View larger version (18K): [in this window] [in a new window]   FIG. 2. Glycerol release from the three skeletal muscle tissue groups was calculated using Fick’s principle and glycerol determinations from the microdialysis measurements together with the blood flow data from respective regions. Data are means ± SE. *P < 0.05 between regions.

The triacylglycerol infusion resulted in a 9-fold increase in plasma glycerol and a 13-fold increase in plasma TG (Fig. 3A). The dialysate concentrations of glycerol for adipose tissue and the muscle regions increased in parallel, and steady-state conditions were reached for all compartments during the last hour of infusion (NS for ANOVA repeated measures). Thus this period was used for calculations. The IA glycerol difference during infusion is shown in Fig. 3B. There was a negative IA glycerol difference in the three skeletal muscle regions during infusion, indicating uptake of glycerol, whereas there was a positive IA glycerol difference in adipose tissue. The IA glycerol difference did not differ among the skeletal muscle regions. Blood flow did not change from basal levels when triacylglycerol was infused. The net glycerol release was calculated as described above, and during glycerol infusion these "release" values were negative (indicating net glycerol uptake) for all skeletal muscle regions, with no significant interregional differences (Fig. 3C).

View larger version (22K): [in this window] [in a new window]   FIG. 3. A: Plasma glycerol and triglycerides in the basal state and during the steady-state period of a 3-h triacylglycerol infusion. The IA glycerol difference (B) and calculated glycerol release/uptake (C) during the infusion are shown.

View larger version (97K): [in this window] [in a new window]   FIG. 4. The presence of adipose tissue in biopsies from vastus lateralis (A) and gastrocnemius (B) muscle regions was identified in muscle sections with the TG-specific dye oil red O. Representative microphotographs from one of the subjects demonstrates that the amounts of adipose tissue in the two muscle regions are visibly similar. The bar indicates the width of the microdialysis catheter (0.45 mm). Note the very small amount of adipose tissue in relation to muscle tissue and the relatively small adipose tissue area that is covered by the microdialysis catheter in relation to pure muscle area.

View larger version (39K): [in this window] [in a new window]   FIG. 5. HSL and perilipin protein are expressed at low but equal levels in muscle. We analyzed 300 µg of total protein from each muscle (gastrocnemius [G] and vastus lateralis [V]) and patient (samples are paired) by Western blot. Then 50 µg of adipose tissue (AT) was run in parallel for comparison. Blots were probed with anti-HSL (A; n = 6) or anti-perilipin (B; n = 4). Note that compared with AT, both proteins are expressed at relatively low levels. However, no obvious difference in expression was observed between the two muscles. Because of technical problems with the Western blot and subsequent lack of tissue, only four samples were available for detection of perilipin protein.

Turnover of triglyceride.
The turnover of muscle TG after an overnight fast was calculated in the gastrocnemius muscle in the set of subjects undergoing muscle biopsy (n = 6). The gastrocnemius muscle was chosen as it was the only muscle group that showed significant glycerol release (3.3 ± 1.4% over 24 h). Using data from our previously published study on healthy nonobese men and women (8), we also calculated the turnover of subcutaneous adipose tissue TG after an overnight fast. The following assumptions were made: 1) 70% of adipose tissue content is lipids, 2) >95% of adipose tissue lipids are TG, and 3) triolein represents the average molecular weight of adipose TG. Glycerol release from the abdominal subcutaneous adipose tissue of lean subjects after an overnight fast was 0.2 ± 0.04 µmol · 100 g^-1 · min^-1 (8), which corresponds to a TG turnover of 0.38 ± 0.07% over 24 h. The latter value is 10 times lower than the presently calculated value for muscle TG turnover (P < 0.01).

Contribution of intramuscular lipolysis to fatty acid oxidation at rest in gastrocnemius muscle.
Fatty acid production by the muscle was calculated using the following: 1) one molecule of glycerol formed equals three molecules of fatty acids formed; 2) the degree of glycerol metabolized was determined to be 0.28 from data in Fig. 3 during steady-state infusion of triacylglycerol according to the formula: ( plasma glycerol - tissue glycerol)/ plasma glycerol, where delta refers to the difference between glycerol during infusion and during baseline; and 3) total glycerol produced by muscle equals net glycerol release multiplied by the correction factor for "true" glycerol production, 1.28.

Estimated fatty acid production at rest was calculated using values for the glycerol release: 0.36 x 3 x 1.28 = 1.4 µmol · kg^-1 · min^-1 or 0.58 x 3 x 1.28 = 2.3 µmol · kg^-1 · min^-1, depeding on if correction for hematocrit was made or not when using Fick’s principle. FFA oxidation at rest in relation to exercise (at 50% of VO_2max) was calculated as follows using data by Schrauwen et al. (37): plasma FFA oxidation at rest/at exercise in healthy nonobese volunteers: 233/972 = 0.24. Muscle oxidation during exercise at 45% of VO_2max in healthy nonobese males is reported by Guo et al. (38) to be 8.2 + 8.4 = 16.6 µmol · kg^-1 · min^-1. Thus, fatty acid oxidation in muscle at rest can be estimated to 0.24 x 16.6 = 4.0 µmol · kg^-1 · min^-1.

	DISCUSSION

TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES

 
The present study demonstrated marked variations in net glycerol release among different human muscle groups. It was found that in healthy subjects the rate of net glycerol release varies among deltoid, vastus lateralis, and gastrocnemius muscle and that a significant net glycerol release was observed only in the skeletal muscle region that had a high portion of type 1 fibers (slow-twitch oxidative fibers), namely, the gastrocnemius muscle. As indicated by the calculation of tissue TG turnover, the actual rate of lipolysis must be very high in gastrocnemius muscle as compared with abdominal subcutaneous adipose tissue, given that a 10-fold difference was observed between these tissue types. However, this difference was probably underestimated because in muscle, in contrast to adipose tissue, an uptake of glycerol may take place (39,40). Also, the differences in lipolysis rates between adipose tissue and muscle may be even greater during nonresting conditions. At rest, the TG pool in gastrocnemius muscle is completely turned over after 1 month. In contrast, during exercise, the muscle TG turnover rate appears to be 10 times faster, with complete turnover taking 3 days (38).

No methods are yet available to enable a mechanistic study of the cause of variation in lipolytic activity among human muscle groups. It is possible that differences are related to fiber composition, as the gastrocnemius muscle has a high content of type 1 fibers plus a high rate of lipolysis. It is tempting to speculate that muscles designed for endurance performance (slow-twitch type 1 fibers) may need an endogenous source of FFAs to a greater extent than do other muscles having a relatively high content of fast-twitch type 2 fibers. It is less likely, though, that the rate of lipolysis is determined by the size of the muscle TG pool. Despite major differences in net glycerol release, the gastrocnemius and vastus lateralis had similar TG contents.

It has been previously established that resting skeletal muscle TG content is largely dependent on the skeletal muscle fiber type, with the highest lipid content being found in type 1 fibers (10,41). We were not able to detect any difference in lipid content between the muscle types with higher and lower portions of type 1 fibers. However, large variations in the triglyceride content from vastus lateralis biopsies have been shown in healthy subjects (42). In our study, the lipid content varied from 10 to 36 µmol/g in the vastus lateralis muscle and from 13 to 42 µmol/g in the gastrocnemius muscle. Of the six subjects studied, only one showed a clearly higher value in the gastrocnemius muscle. The fiber type composition is also reported to be largely variable (43,44), at least in the vastus lateralis muscle. The proportion we found is in agreement with previous findings in healthy subjects (44).

Using present techniques, it is not possible to establish the exact origin of tissue glycerol. Glycerol can be released from intramuscular TG (intracellular), from TG in adipocytes marbled between the myocytes (extracellular), or from local breakdown of TG delivered by the blood stream through the activity of lipoprotein lipase (LPL). In exercising muscle, there is evidence of a fiber type-dependent utilization of intracellular TG, so that the slow- twitch (type 1) fibers are capable of a larger turnover of TG (45). If this also holds true for resting muscle, then the gastrocnemius muscle should release more glycerol from intramuscular TG because of the relative dominance of type 1 fibers. Unfortunately, the present sample size was too small to allow correlation statistics to be performed between fiber type and glycerol release. LPL is mainly activated by decreased intracellular TG to replenish intracellular TG stores from extracellular TG after, for example, exercise (46). It is also possible that it contributes to glycerol release in the fasted state. TG from adipocytes within the muscle is the third alternative source of glycerol. However, it seems unlikely that the glycerol recovered in microdialysis experiments of skeletal muscle originates from adipocytes. First, there was no important difference in local TG content between two of the different muscle groups studied (vastus lateralis and gastrocnemius). Second, the histological examination of extramyocytic TG showed very small amounts of adipocyte-derived TG staining. Third, only diminutive amounts of the adipocyte-specific proteins perilipin in the muscles were investigated, with no differences found between the two regions. If adipocytes were responsible for the substantial contrasts in net glycerol release, adipocyte-specific proteins would be present in protein lysates from muscle in amounts correlating to the quantity of contaminating adipose tissue. Fourth, there is no reason to believe that muscle fat cells have a much higher turnover rate than do adipose tissue fat cells.

Another reason for the interregional differences in glycerol release could be differences in glycerol uptake in the respective muscles. However, this seems less likely as the glycerol fractional extraction (IA difference) as well as the calculated glycerol uptake was similar in the three regions when circulating glycerol was artificially increased well above tissue levels. Moreover, because the tissue blood flow was constant during the infusion experiment, an estimate of the uptake of infused glycerol can be performed using the formula: ( plasma glycerol - tissue glycerol)/ plasma glycerol, where delta refers to the difference between glycerol during infusion and baseline. It can be assumed that during circumstances with markedly increased circulating glycerol, the skeletal muscle tissue glycerol uptake is still at most 20–30% of the infused glycerol. Furthermore, there were no differences among the regions. Differences in glycerol uptake is therefore not considered to explain the large difference (400%) in glycerol release found in different skeletal muscle regions. Direct reutilization within the myocyte of glycerol derived from intramuscular lipolysis could theoretically be subject to regional variations that could not be evaluated in the present study.

When calculating glycerol release, we used a constant permeability surface product area (PS value) of 5 ml · 100 g^-1 · min^-1. As extensively reviewed by Crone and Levitt (47), it has been experimentally shown that the PS values for low-molecular substances (e.g., glycerol) are comparable in most organs with continuous capillaries, including skeletal muscle and adipose tissue. Thus we do not believe that skeletal muscle regional differences in the PS values could be of importance for the findings. Moreover, to abolish the regional differences found, the PS value for the gastrocnemius muscle has to be <3 ml · 100 g^-1 · min^-1 or increased >100-fold in the gastrocnemius region.

Present and previous data (current study; 8,25) indicate that there are major differences in the regulation of lipolysis in muscle and adipose tissue. The action of the most important hormones, insulin and catecholamines, differ. Some muscle groups may have no or little lipolytic activity at rest, whereas others may have lipolysis rates far exceeding those seen in adipose tissue, as estimated from TG turnover data. These differences among and within tissues might be important not only for normal regulation of energy homeostasis but also for the development of insulin-resistant conditions.

We found higher glycerol levels in muscle than in blood at rest (22) than did Rosdahl et al. (48), who used similar microdialysis techniques. The present results most likely explain the divergence in these reports. We investigated the gastrocnemius muscle, whereas Rosdahl and colleagues studied the vastus lateralis muscle. It is apparent that regional differences in metabolic activity must be considered when interpreting data from a single muscle group.

It would be of interest to investigate the extent to which intracellular triglyceride lipolysis contributes to fatty acid oxidation in skeletal muscle at rest. We calculated that in gastrocnemius muscle, the production of fatty acids by intramuscular lipolysis was 1.4–2.3 µmol · kg^-1 · min^-1, depending on the mode of calculation. Furthermore, we calculated that fatty acid oxidation in skeletal muscle at rest is 4 µmol · kg^-1 · min^-1. If we assume that after an overnight fast essentially all fatty acids produced in resting muscle are oxidized, then muscle lipolysis contributes 33–50% of the fatty acid oxidation in gastrocnemius muscle. Interestingly, Guo et al. (38) found that during exercise, half of the fatty acids oxidized derived from intramuscular lipolysis. The data of Guo and colleagues probably represent several muscle groups, and we do not know if there are also differences among muscle groups in local lipolysis during exercise. Because we found no evidence of significant net glycerol release in any muscle group except gastrocnemius, it is likely that local lipolysis is important to the energy supply in the resting state only in this muscle group.

In summary, the findings of this study indicated that there are significant differences in resting lipolytic activity among different skeletal muscle groups in healthy nonobese humans. Net glycerol release, indicative of lipolytic activity, was observed from only the gastrocnemius muscle, which is mainly composed of type 1 muscle fibers. This suggests that local lipolysis is most important for endurance muscle activity.

	ACKNOWLEDGMENTS

 
This study was supported by grants from the Swedish Medical Research Council, Pharmacia and Upjohn, the Karolinska Institute, the Swedish Diabetes Association, the Swedish Heart and Lung Foundation, Novo Nordisk Pharma, and the Thuring Foundation.

The excellent technical assistance of Lisa Dungner, Eva Sjölin, Britt-Marie Leijonhufvud, and Katarina Hertel is acknowledged.

	FOOTNOTES

 
Address correspondence and reprint requests to Dr. Eva Hagström-Toft, Center of Metabolism and Endocrinology, M63, Huddinge University Hospital, SE-141 86 Stockholm, Sweden. E-mail: eva.toft{at}ersta.se.

Received for publication 24 August 2001 and accepted in revised form 26 August 2002.

FFA, free fatty acid; H-E, hematoxylin-eosin; HSL, hormone-sensitive lipase; IA, interstitial-arterial; LPL, lipoprotein lipase; PS value, permeability surface product area; TBF, tissue blood flow; TG, triglyceride.

	REFERENCES

TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES

 

1. Reaven GM, Hollenbeck C, Jeng C-Y, Wu MS, Chen YD: Measurements of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes37 :1020 –1024,1988[Abstract]
2. Groop LC, Bonadonna RC, Simonson DC, Petrides AS, Shank M, DeFronzo RA: Effect of insulin on oxidative and non-oxidative pathways of free fatty acid metabolism in human obesity. Am J Physiol263 :E79 –E84,1992[Abstract/Free Full Text]
3. Björntorp P: Fatty acids, hyperinsulinemia, and insulin resistance. Which comes first? Curr Opin Lipidol5 :166 –174,1994[Medline]
4. Boden G: Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes46 :3 –10,1997[Abstract]
5. Frayn KN, Williams CM, Arner P: Are increased plasma non-esterified fatty acid concentrations a risk marker for coronary heart disease and other chronic diseases? Clin Sci90 :243 –253,1996[Medline]
6. Maggs DG, Jacob R Rife F, Lange R, Leone P, During MJ, Tamborlane WV, Sherwin RS: Interstitial fluid concentrations of glycerol, glucose and amino acids in human quadriceps muscle and adipose tissue. J Clin Invest96 :370 –377,1995[Medline]
7. Stumvoll M, Jacob S, Wahl HG, Hauer B, Löblein K, Grauer P, Becker R, Nielsen M, Renn W, Häring H: Suppression of systemic intramuscular and subcutaneous adipose tissue lipolysis by insulin in humans. J Clin Endocrinol Metab85 :3740 –3745,2000[Abstract/Free Full Text]
8. Bolinder J, Kerckhoffs D, Moberg E, Hagström-Toft E, Arner P: Rates of skeletal muscle and adipose tissue glycerol release in nonobese and obese subjects. Diabetes49 :797 –802,2000[Abstract]
9. Goodpaster BH, Theriault R, Watkins SC, Kelley DE: Intramuscular lipid content is increased in obesity and decreased by weight loss. Metabolism49 :467 –472,2000[Medline]
10. He J, Watkins S, Kelley DE: Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes50 :817 –823,2001[Abstract/Free Full Text]
11. Ebeling P, Essén-Gustafsson B, Tuominen JA, Koivisto VA: Intramuscular triglyceride content is increased in IDDM. Diabetologia41 :111 –115,1998[Medline]
12. Krssak M, Falk Petersen K, Dresner A, Di Petro L, Vogel SM, Rothman DL, Roden M, Shulman GI: Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a ¹H NMR spectroscopy study. Diabetologia42 :113 –116,1999[Medline]
13. Philips DI, Caddy S, Ilic V, Fielding BA, Frayn KN, Borthwick AC, Taylor R: Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism45 :947 –950,1996[Medline]
14. Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogardus C, Jenkins AB, Storlien LH: Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes46 :983 –988,1997[Abstract]
15. Enocksson S, Shimizu M, Lonnqvist F, Nordenstrom J, Arner P: Demonstration of an in vivo functional beta 3-adrenoceptor in man. J Clin Invest95 :2239 –2245,1995[Medline]
16. Hagström-Toft E, Enoksson S, Moberg E, Bolinder J, Arner P: Beta-adrenergic regulation of lipolysis and blood flow in human skeletal muscle in vivo. Am J Physiol275 :E909 –E916,1998[Abstract/Free Full Text]
17. Arner P: Differences in lipolysis between human subcutaneous and omental adipose tissues. Ann Med27 :435 –438,1995[Medline]
18. Guo Z, Jensen MD: Intramuscular fatty acid metabolism evaluated with stable isotopic tracers. J Appl Physiol84 :1674 –1679,1998[Abstract/Free Full Text]
19. Peters SJ, Dyck DJ, Bonen A, Spriet LL: Effects of epinephrine on lipid metabolism in resting skeletal muscle. Am J Physiol275 :E300 –E309,1998[Medline]
20. Lafontan M, Arner P: Application of in situ microdialysis to measure metabolic and vascular responses in adipose tissue. Trends Pharmacol Sci17 :309 –313,1996[Medline]
21. Abumrad NN, Rabin D, Diamond MP, Lacy WW: Use of heated superficial hand vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man. Metabolism30 :936 –940,1981[Medline]
22. Hagström-Toft E, Enoksson S, Moberg E, Bolinder J, Arner P: Absolute concentrations of glycerol and lactate in human skeletal muscle, adipose tissue, and blood. Am J Physiol273 :E584 –E592,1997[Abstract/Free Full Text]
23. Larsen OA, Lassen NA, Quaade F: Blood flow through human adipose tissue determined with radioactive xenon. Acta Physiol Scand66 :337 –345,1966[Medline]
24. Sejrsen P, Tönnesen KH: Inert gas diffusion method for measurement of blood flow using saturation techniques: comparison with directly measured blood flow in isolated gastrocnemius muscle of the cat. Clin Res22 :679 –689,1964
25. Hagström-Toft E, Thorne A, Reynisdottir S, Moberg E, Rossner S, Bolinder J, Arner P: Evidence for a major role of skeletal muscle lipolysis in the regulation of lipid oxidation during caloric restriction in vivo. Diabetes50 :1604 –1611,2001[Abstract/Free Full Text]
26. Ek I, Arner P, Ryden M, Holm C, Thorne A, Hoffstedt J, Wahrenberg H: A unique defect in the regulation of visceral fat cell lipolysis in the polycystic ovary syndrome as an early link to insulin resistance. Diabetes51 :484 –492,2002[Abstract/Free Full Text]
27. Hellmér J, Arner P, Lundin A: Automatic luminometric kinetic assay of glycerol for lipolysis studies. Anal Biochem177 :132 –137,1989[Medline]
28. Arner P, Ostman J: Mono-acid diacylglycerols in human adipose tissue. Biochim Biophys Acta18 :209 –221,1974
29. Carpenter S, Karpati G: Structures and reaction. In Pathology of Skeletal Muscle. 2nd ed. Carpenter S, Karpati G, Eds. Oxford, U.K., Oxford University Press,2001 , p.3 –27
30. Lassen NA, Lindbjerg IF, Munck O: Measurement of blood flow through skeletal muscle by intramuscular injection of ¹³³Xenon. Lanceti :686 –689,1964
31. Lassen NA: Capillary diffusion capacity of sodium studied by the clearance of Na-24 and Xe-133 from hyperemic skeletal muscle in man. J Clin Lab Invest19 (Suppl. 99) :24 –26,1967
32. Carlsen A, Wieth JO: Glycerol transport in human red cells. Acta Physiol Scand97 :501 –513,1976[Medline]
33. Sansom MS, Law RJ: Membrane proteins. Aquaporins: channels without ions. Curr Biol23 :R71 –R73,2001
34. Roudier N, Verbavatz JM, Maurel C, Ripoche P, Tacnet F: Evidence for the presence of aquaporin-3 in human red blood cells. J Biol Chem273 :8407 –8412,1998[Abstract/Free Full Text]
35. Laurell S, Tibbling G: An enzymatic fluorometric micromethod for the determination of glycerol. Clin Chem Acta13 :317 –322,1966[Medline]
36. Londos C, Gruia-Gray J, Brasaemle DL, Rondinone CM, Takeda T, Dwyer NK, Barber T, Kimmel AR, Blanchette-Mackie EJ: Perilipin: possible roles in structure and metabolism of intracellular neutral lipids in adipocytes and steroidogenic cells. Int J Obes Relat Metab Disord3 :97 –101,1996
37. Schrauwen P, van Aggel-Leijssen DPC, Hul G, Waagenmakers AJM, Vidal H, Saris WHM, van Baak MA: The effect of a 3-month low-intensity endurance training program on fat oxidation and acetyl-CoA carboxylase-2 expression. Diabetes51 :2220 –2226,2002[Abstract/Free Full Text]
38. Guo Z, Burguera B, Jensen MD: Kinetics of intramuscular triglyceride fatty acids in exercising humans. J Appl Physiol89 :2057 –2064,2000[Abstract/Free Full Text]
39. Frayn KN, Coppack SW, Humphreys SM: Glycerol and lactate uptake in human forearm. Metabolism40 :1317 –1319,1991[Medline]
40. Coppack SW, Persson M, Judd RL, Miles JM: Glycerol and nonesterified fatty acid metabolism in human muscle and adipose tissue in vivo. Am J Physiol276 :E233 –E240,1999[Abstract/Free Full Text]
41. Gorski J: Muscle triglyceride metabolism during exercise. Can J Physiol Pharmacol70 :123 –131,1990 .
42. Wendlin PS, Peters SJ, Heignehauser GJF, Spriet LL: Variability of triacylglycerol content in human skeletal muscle biopsy samples. J Appl Physiol81 :1150 –1155,1996 .[Abstract/Free Full Text]
43. Simoneau J-A, Bouchard C: Genetic determinism of fiber type proportion in human skeletal muscle. FASEB J9 :1091 –1095,1995 .[Abstract]
44. Staron RS, Hagerman FC, Hikida RS, Murray TF, Hostler DP, Crill MT, Ragg KE, Toma K: Fiber type composition of the vastus lateralis muscle of young men and women. J Histochem Cytochem48 :623 –629,2000 .[Abstract/Free Full Text]
45. Rico-Sanz J, Moosavi M, Thomas EL, McCarthy J, Coutts GA, Saeed N, Bell JD: In vivo evaluation of the effects of continuous exercise on skeletal muscle triglycerides in trained humans. Lipids35 :1313 –1318,2000 .[Medline]
46. Oscai LB, Essig DA, Palmer WK: Lipase regulation of muscle triglyceride hydrolysis. J Appl Physiol69 :1571 –1577,1990[Abstract/Free Full Text]
47. Crone C, Levitt DG: Capillary permeability to small solutes. In Handbook of Physiology: The Cardiovascular System IV. Renkin EM, Michel CC, Geiger SR, Eds. Bethesda, MD, American Physiological Society,1984 , p.411 –466
48. Rosdahl H, Hamrin K, Ungerstedt U, Henriksson J: Metabolite levels in human skeletal muscle and adipose tissue studied with microdialysis at low perfusion flow. Am J Physiol274 :E936 –E945,1998

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				J. W.E. Jocken, C. Roepstorff, G. H. Goossens, P. van der Baan, M. van Baak, W. H.M. Saris, B. Kiens, and E. E. Blaak Hormone-Sensitive Lipase Serine Phosphorylation and Glycerol Exchange Across Skeletal Muscle in Lean and Obese Subjects: Effect of {beta}-Adrenergic Stimulation Diabetes, July 1, 2008; 57(7): 1834 - 1841. [Abstract] [Full Text] [PDF]

				T. H. Reynolds IV, M. A. Supiano, and D. R. Dengel Regional differences in glucose clearance: effects of insulin and resistance training on arm and leg glucose clearance in older hypertensive individuals J Appl Physiol, March 1, 2007; 102(3): 985 - 991. [Abstract] [Full Text] [PDF]

				V. Qvisth, E. Hagstrom-Toft, E. Moberg, S. Sjoberg, and J. Bolinder Lactate release from adipose tissue and skeletal muscle in vivo: defective insulin regulation in insulin-resistant obese women Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E709 - E714. [Abstract] [Full Text] [PDF]

				E. Bernroider, A. Brehm, M. Krssak, C. Anderwald, Z. Trajanoski, G. Cline, G. I. Shulman, and M. Roden The Role of Intramyocellular Lipids during Hypoglycemia in Patients with Intensively Treated Type 1 Diabetes J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5559 - 5565. [Abstract] [Full Text] [PDF]

				D. B. Olsen, M. Sacchetti, F. Dela, T. Ploug, and B. Saltin Glucose clearance is higher in arm than leg muscle in type 2 diabetes J. Physiol., June 1, 2005; 565(2): 555 - 562. [Abstract] [Full Text] [PDF]

				M. Sacchetti, B. Saltin, D. B Olsen, and G. van Hall High triacylglycerol turnover rate in human skeletal muscle J. Physiol., December 15, 2004; 561(3): 883 - 891. [Abstract] [Full Text] [PDF]

				V. Qvisth, E. Hagstrom-Toft, S. Enoksson, R. S. Sherwin, S. Sjoberg, and J. Bolinder Combined Hyperinsulinemia and Hyperglycemia, But Not Hyperinsulinemia Alone, Suppress Human Skeletal Muscle Lipolytic Activity in Vivo J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4693 - 4700. [Abstract] [Full Text] [PDF]

				C. Schoelch, J. Kuhlmann, M. Gossel, G. Mueller, C. Neumann-Haefelin, U. Belz, J. Kalisch, G. Biemer-Daub, W. Kramer, H.-P. Juretschke, et al. Characterization of Adenosine-A1 Receptor-Mediated Antilipolysis in Rats by Tissue Microdialysis, 1H-Spectroscopy, and Glucose Clamp Studies Diabetes, July 1, 2004; 53(7): 1920 - 1926. [Abstract] [Full Text] [PDF]

				L. C. C. Navegantes, M. Sjostrand, S. Gudbjornsdottir, L. Strindberg, M. Elam, and P. Lonnroth Regulation and Counterregulation of Lipolysis in Vivo: Different Roles of Sympathetic Activation and Insulin J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5515 - 5520. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager